3qs5: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Crystal structure of LeuT mutant I359Q bound to sodium and L-tryptophan== | ==Crystal structure of LeuT mutant I359Q bound to sodium and L-tryptophan== | ||
<StructureSection load='3qs5' size='340' side='right' caption='[[3qs5]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='3qs5' size='340' side='right'caption='[[3qs5]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3qs5]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[3qs5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/"aquifex_aeolicus"_huber_and_stetter_2001 "aquifex aeolicus" huber and stetter 2001]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QS5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3QS5 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BOG:B-OCTYLGLUCOSIDE'>BOG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=TRP:TRYPTOPHAN'>TRP</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BOG:B-OCTYLGLUCOSIDE'>BOG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=TRP:TRYPTOPHAN'>TRP</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2a65|2a65]], [[3f3a|3f3a]], [[3qs4|3qs4]], [[3qs6|3qs6]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2a65|2a65]], [[3f3a|3f3a]], [[3qs4|3qs4]], [[3qs6|3qs6]]</div></td></tr> | ||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">aq_2077, leut, snf ([ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">aq_2077, leut, snf ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=63363 "Aquifex aeolicus" Huber and Stetter 2001])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3qs5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3qs5 OCA], [https://pdbe.org/3qs5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3qs5 RCSB], [https://www.ebi.ac.uk/pdbsum/3qs5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3qs5 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
Line 21: | Line 21: | ||
==See Also== | ==See Also== | ||
*[[Leucine transporter|Leucine transporter]] | *[[Leucine transporter|Leucine transporter]] | ||
*[[Symporter 3D structures|Symporter 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
Line 26: | Line 27: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Aquifex aeolicus huber and stetter 2001]] | [[Category: Aquifex aeolicus huber and stetter 2001]] | ||
[[Category: Large Structures]] | |||
[[Category: Gouaux, E]] | [[Category: Gouaux, E]] | ||
[[Category: Piscitelli, C L]] | [[Category: Piscitelli, C L]] |
Revision as of 09:21, 8 June 2022
Crystal structure of LeuT mutant I359Q bound to sodium and L-tryptophanCrystal structure of LeuT mutant I359Q bound to sodium and L-tryptophan
Structural highlights
Publication Abstract from PubMedLeuT is a bacterial homologue of the neurotransmitter:sodium symporter (NSS) family and, being the only NSS member to have been structurally characterized by X-ray crystallography, is a model protein for studying transporter structure and mechanism. Transport activity in LeuT was hypothesized to require structural transitions between open-to-out and occluded conformations dependent upon protein:ligand binding complementarity. Here, using crystallographic and functional analysis, we show that binding site modification produces changes in both structure and activity that are consistent with complementarity-dependent structural transitions to the occluded state. The mutation I359Q converts the activity of tryptophan from inhibitor to transportable substrate. This mutation changes the local environment of the binding site, inducing the bound tryptophan to adopt a different conformer than in the wild-type complex. Instead of trapping the transporter open, tryptophan binding now allows the formation of an occluded state. Thus, transport activity is correlated to the ability of the ligand to promote the structural transition to the occluded state, a step in the transport cycle that is dependent on protein:ligand complementarity in the central binding site. Insights into transport mechanism from LeuT engineered to transport tryptophan.,Piscitelli CL, Gouaux E EMBO J. 2011 Sep 27. doi: 10.1038/emboj.2011.353. PMID:21952050[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|